Blog
SpeciCare
For more than 35 years, Ken Dixon, M.D., FACS, a surgeon with Surgical Oncology of Northeast Georgia, has treated cancer patients in his practice located in Gainesville, Ga. After a lifetime taking care of cancer patients, and telling a patient or a family member ‘there is nothing left to do’ Dr. Dixon began a journey to do more. Hear more of Dr. Dixon’s thoughts directly from him from this blog.
Why Billions are Being Invested in the Future of Cancer Care
Cancer care is in the middle of a quiet revolution—and the smartest money in healthcare has noticed. In the last few weeks alone: Abbott announced a ~$21–23 billion acquisition of Exact Sciences, the company behind Cologuard and major precision-oncology assays like...
Abbott Just Bet $21 Billion on Advanced Cancer Testing – Why It’s a Good Bet
The $21 Billion Wake-Up Call Advanced Cancer Testing Is Eating Standard Cancer Care When a global medtech giant like Abbott spends about $21 billion to acquire a cancer-testing company, it’s not just a business headline—it’s a message about where cancer care is really...
Losing The Cancer Treatment Lottery
Losing The Cancer Treatment Lottery Why Half of New Cancer Patients Are Getting the Wrong Treatment First When Sarah received her breast cancer diagnosis, her oncologist immediately prescribed a standard chemotherapy regimen. Three months, countless side effects, and...
The Ugly Truth in Cancer Treatment
In the fight against cancer, we celebrate every medical breakthrough—every new targeted therapy, every successful clinical trial, and every technology promising a more personalized approach. Yet, beneath the surface of this rapid advancement lies a startling, systemic failure in the most foundational step of a patient’s journey: the preservation of their diagnostic tissue.
Preserving Possibility- Why Tissue Cryopreservation Should Be Offered to Every Biopsy Patient
Specicare is a leading biomedical services company dedicated to advancing personalized medicine and clinical research. The company offers a comprehensive suite of services critical to both patient care and scientific discovery. These services include the meticulous cryopreservation and storage of tissue and blood samples, specialized clinical trials management and matching to connect patients with appropriate studies, and detailed electronic medical record summaries to streamline data. Furthermore, Specicare supports therapeutic development through Tissue Licensing, ex-vivo drug panel testing for individualized treatment strategies, and advanced genomics testing to unlock genetic insights.
The Future of Precision Cancer Care at the National Cancer Institute
The world of oncology has been galvanized by the news of Dr. Anthony Letai's appointment as the new Director of the National Cancer Institute (NCI). This is not merely a political or administrative change; it signals a decisive move towards a future defined by...